Literature DB >> 29712875

Roles of Alanine Dehydrogenase and Induction of Its Gene in Mycobacterium smegmatis under Respiration-Inhibitory Conditions.

Ji-A Jeong1, Sae Woong Park2, Dahae Yoon3, Suhkmann Kim3, Ho-Young Kang1, Jeong-Il Oh4.   

Abstract

Here we demonstrated that the inhibition of electron flux through the respiratory electron transport chain (ETC) by either the disruption of the gene for the major terminal oxidase (aa3 cytochrome c oxidase) or treatment with KCN resulted in the induction of ald encoding alanine dehydrogenase in Mycobacterium smegmatis A decrease in functionality of the ETC shifts the redox state of the NADH/NAD+ pool toward a more reduced state, which in turn leads to an increase in cellular levels of alanine by Ald catalyzing the conversion of pyruvate to alanine with the concomitant oxidation of NADH to NAD+ The induction of ald expression under respiration-inhibitory conditions in M. smegmatis is mediated by the alanine-responsive AldR transcriptional regulator. The growth defect of M. smegmatis by respiration inhibition was exacerbated by inactivation of the ald gene, suggesting that Ald is beneficial to M. smegmatis in its adaptation and survival under respiration-inhibitory conditions by maintaining NADH/NAD+ homeostasis. The low susceptibility of M. smegmatis to bcc1 complex inhibitors appears to be, at least in part, attributable to the high expression level of the bd quinol oxidase in M. smegmatis when the bcc1-aa3 branch of the ETC is inactivated.IMPORTANCE We demonstrated that the functionality of the respiratory electron transport chain is inversely related to the expression level of the ald gene encoding alanine dehydrogenase in Mycobacterium smegmatis Furthermore, the importance of Ald in NADH/NAD+ homeostasis during the adaptation of M. smegmatis to severe respiration-inhibitory conditions was demonstrated in this study. On the basis of these results, we propose that combinatory regimens including both an Ald-specific inhibitor and respiration-inhibitory antitubercular drugs such as Q203 and bedaquiline are likely to enable a more efficient therapy for tuberculosis.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  AldR transcriptional regulator; Mycobacterium; alanine dehydrogenase; electron transport chain; gene expression; redox homeostasis; respiration

Mesh:

Substances:

Year:  2018        PMID: 29712875      PMCID: PMC6018359          DOI: 10.1128/JB.00152-18

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  63 in total

1.  Roles of the two type II NADH dehydrogenases in the survival of Mycobacterium tuberculosis in vitro.

Authors:  Disha Awasthy; Anisha Ambady; Ashwini Narayana; Sapna Morayya; Umender Sharma
Journal:  Gene       Date:  2014-08-13       Impact factor: 3.688

2.  Bactericidal mode of action of bedaquiline.

Authors:  Kiel Hards; Jennifer R Robson; Michael Berney; Lisa Shaw; Dirk Bald; Anil Koul; Koen Andries; Gregory M Cook
Journal:  J Antimicrob Chemother       Date:  2015-03-08       Impact factor: 5.790

3.  Thermostable alanine dehydrogenase from thermophilic Bacillus sphaericus DSM 462. Purification, characterization and kinetic mechanism.

Authors:  T Ohshima; M Sakane; T Yamazaki; K Soda
Journal:  Eur J Biochem       Date:  1990-08-17

4.  Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.

Authors:  Garrett C Moraski; Lowell D Markley; Philip A Hipskind; Helena Boshoff; Sanghyun Cho; Scott G Franzblau; Marvin J Miller
Journal:  ACS Med Chem Lett       Date:  2011-06-09       Impact factor: 4.345

5.  Hypoxia-activated cytochrome bd expression in Mycobacterium smegmatis is cyclic AMP receptor protein dependent.

Authors:  Htin Lin Aung; Michael Berney; Gregory M Cook
Journal:  J Bacteriol       Date:  2014-06-16       Impact factor: 3.490

6.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

7.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

8.  Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins.

Authors:  Ida Rosenkrands; Richard A Slayden; Janne Crawford; Claus Aagaard; Clifton E Barry; Peter Andersen
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

9.  Identification of the dehydratase component of the mycobacterial mycolic acid-synthesizing fatty acid synthase-II complex.

Authors:  Alistair K Brown; Apoorva Bhatt; Albel Singh; Elesh Saparia; Alex F Evans; Gurdyal S Besra
Journal:  Microbiology       Date:  2007-12       Impact factor: 2.777

10.  Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia.

Authors:  Wai Yee Phong; Wenwei Lin; Srinivasa P S Rao; Thomas Dick; Sylvie Alonso; Kevin Pethe
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more
  9 in total

1.  Tripartite Regulation of the glpFKD Operon Involved in Glycerol Catabolism by GylR, Crp, and SigF in Mycobacterium smegmatis.

Authors:  Hyun-Ju Bong; Eon-Min Ko; Su-Yeon Song; In-Jeong Ko; Jeong-Il Oh
Journal:  J Bacteriol       Date:  2019-11-20       Impact factor: 3.490

2.  Regulation of the icl1 Gene Encoding the Major Isocitrate Lyase in Mycobacterium smegmatis.

Authors:  Eon-Min Ko; Ju-Yeon Kim; Sujin Lee; Suhkmann Kim; Jihwan Hwang; Jeong-Il Oh
Journal:  J Bacteriol       Date:  2021-09-13       Impact factor: 3.490

3.  Activation of the SigE-SigB signaling pathway by inhibition of the respiratory electron transport chain and its effect on rifampicin resistance in Mycobacterium smegmatis.

Authors:  Yuna Oh; Hye-In Lee; Ji-A Jeong; Seonghan Kim; Jeong-Il Oh
Journal:  J Microbiol       Date:  2022-08-01       Impact factor: 2.902

4.  Negative regulation of the acsA1 gene encoding the major acetyl-CoA synthetase by cAMP receptor protein in Mycobacterium smegmatis.

Authors:  Eon-Min Ko; Yuna Oh; Jeong-Il Oh
Journal:  J Microbiol       Date:  2022-10-24       Impact factor: 2.902

Review 5.  Alanine dehydrogenases in mycobacteria.

Authors:  Ji-A Jeong; Jeong-Il Oh
Journal:  J Microbiol       Date:  2019-01-31       Impact factor: 3.422

6.  The Small Protein CydX Is Required for Cytochrome bd Quinol Oxidase Stability and Function in Salmonella enterica Serovar Typhimurium: a Phenotypic Study.

Authors:  Kieu Minh Duc; Bo Gyeong Kang; Choa Lee; Hee Jeong Park; Yoon Mee Park; Young Hee Joung; Iel Soo Bang
Journal:  J Bacteriol       Date:  2020-01-02       Impact factor: 3.490

7.  A Master Regulator of Bacteroides thetaiotaomicron Gut Colonization Controls Carbohydrate Utilization and an Alternative Protein Synthesis Factor.

Authors:  Guy E Townsend; Weiwei Han; Nathan D Schwalm; Xinyu Hong; Natasha A Bencivenga-Barry; Andrew L Goodman; Eduardo A Groisman
Journal:  mBio       Date:  2020-01-28       Impact factor: 7.867

8.  Induction of the cydAB Operon Encoding the bd Quinol Oxidase Under Respiration-Inhibitory Conditions by the Major cAMP Receptor Protein MSMEG_6189 in Mycobacterium smegmatis.

Authors:  Eon-Min Ko; Jeong-Il Oh
Journal:  Front Microbiol       Date:  2020-11-30       Impact factor: 5.640

9.  Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension.

Authors:  Boatema Ofori-Anyinam; Abi Janet Riley; Tijan Jobarteh; Ensa Gitteh; Binta Sarr; Tutty Isatou Faal-Jawara; Leen Rigouts; Madikay Senghore; Aderemi Kehinde; Nneka Onyejepu; Martin Antonio; Bouke C de Jong; Florian Gehre; Conor J Meehan
Journal:  Tuberculosis (Edinb)       Date:  2020-01-08       Impact factor: 3.131

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.